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Abstract
Gastrointestinal stromal tumors (GISTs) are rare tumors and can 
be a cause of gastrointestibnal bleeding, when other causes have 
already been excluded. This mesenchymal tumors can be diagnosed 
hardly, and they should be included in any differential diagnosis. 
Our case illustrates the difficulty of diagnosis and sometimes shows 
how non-invasive test can be few helpful. Surgery is very often 
indicated, and becomes therapeutic and diagnostic. GIST tumors 
are rare and surgical resection with curative intent is the treatment 
of choice.
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Introduction
Gastrointestinal stromal tumors (GISTs) are uncommon and 
can be a cause of obscure hemorrage when conventional 
investigations such as esophagogastroduodenoscopy and 
colonoscopy fail to detect bleeding lesions. GIST tumors, a 
rare group of neoplasias of the gastrointestinal tract (GI) and 
considered to be cause of obscure GI bleeding, have small 
intestinal lesions in 27% of the patients [1]. 
GISTs are mesenchymal tumors specific for the GI tract 
(60% in stomach, 30% small intestine, 10% elsewhere). 
From 10 to 30% of them are malignant and show liver me-
tastases or intra-abdominal spread, they represent only 3% of 
all malignant GI tumors [2]. 
The first series of GISTs were reported by Golden and 
Stout [3]. The digestive hemorrhage occurs very often be-
cause they often grow in an extraluminal direction and if 
they erode or ulcerate through the small bowel mucosa they 
can cause intermittent bleeding. The abdominal pain, ab-
dominal mass, obstruction or the perforations are the main 
symptoms [4].
Diagnosing these lesions is difficult because they tend to 
be inaccessible to routine endoscopy, like in our case. Vari-
able sensitivities and specificities for diagnosing small in-
testinal lesions are found with small bowel barium studies, 
selective visceral angiography, wireless capsule endoscopy, 
radioactive isotope bleeding scans and exploratory laparoto-
my is often the last option [5, 6]. We do present our experi-
ence in a patient  with a gastrointestinal stromal tumor with 
bleeding.
 
Case Report
  
A 77-year-old woman presented with 3 days of hematoche-
zia associated with mild lower abdominal. The patient had 
hypertension, obesity and in the past medical history was a 
history of a bleeding in 2 occasions, requiring blood transfu-
sion, and attributed to gastric ulcers treated.
Physical examination on admission revealed conjunc-
tival pallor. Workup included an esophagogastroduodenos-
copy with negative results, a colonoscopy showing blood 
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Figure 1. Jejunal highly vascular mass on the antimesenteric 
border.
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throughout the colon, diverticulosis and fresh bleeding from 
the terminal ileum.
A computed tomography scan was performed and 
showed a 4 x 4 cm mass in the ileal area. A celiac and supe-
rior mesenteric artery angiogram revealed a highly vascular 
midjejunal mass on the antimesenteric border of the bowel. A 
laparotomy was performed and the tumor was excised (Fig. 
1) and identified histologically as a gastrointestinal stromal 
tumor (GIST), with c-Kit (CD117 and CD34) markers posi-
tive. The patient recovered postoperatively without incidenc-
es and is clinically stable at 3 years postresection, without 
evidence of recurrent disease on follow-up CT scans.
Discussion
  
Reaching the diagnostic of small intestine hemorrhage is 
difficult, and in as many as 5% of patients with obscure GI 
bleeding, a source cannot be identified despite extensive ex-
amination [7]. In many occasions, lesions cannot be identi-
fied after upper endoscopy and colonoscopy, and more spe-
cific studies must be performed to explore the small intestine 
such as enteroclysis, sonde enteroscopy, wireless capsule 
endoscopy or even intraoperative enteroscopy [8].
Tumors and vascular ectasias are the lesions most com-
monly identified as bleeding sites in the small bowel in old 
patients. In patients with less than 25 years of age, Meckel’s 
diverticulum is the most common source of small bowel 
bleeding [8]. 
Some other rare causes of GI hemorrhage include hemo-
bilia, Dieulafoy lesion, aortoenteric fistula, extraesophageal 
varices, and diverticula. GIST should be considered in the 
differential diagnosis for GI bleeding. These tumors, in 50% 
of the cases, presented with subacute or acute GI bleeding 
[9].
GISTs are the most common mesenchymal tumors of the 
stomach and small intestine [10]. They possess unique his-
tologic, immunophenotypic, and molecular genetic features 
that set them apart from typical leiomyomas and schwanno-
mas [10]. GIST’s immunohistochemical staining is usally 
positive for CD117 (c-Kit protein) and CD34 (hematopoietic 
cell progenitor cell antigen), like in our case [11]. 
GISTs are typically discovered incidentally during en-
doscopic, radiologic, or surgical procedures or are diagnosed 
in the evaluation of patients presenting with an abdominal 
mass, abdominal pain, or GI bleeding. 
Surgical resection with curative intent is the treatment 
of choice with localized GIST [12]. Complete resection of 
the tumor should be always performed, because recurrence 
can appear. The extent of surgical excision and survival has 
no relationship [9]. If feasible limited resection is possible, 
those should be performed, because an adequate extended 
resection provides no survival benefit over wide local exci-
sion [9].
Approximately 10% of all GISTs display malignant be-
haviour [10]. When the maximal diameter of the GISTs is su-
perior to 10 cm, malignancy should be considered. Further-
more, this tumor shows mucosal ulceration, necrotic areas 
and hemorrhage [10]. Cytologic atypia is not always seen, 
and this makes more difficult the diagnosis. 
Concerning the hemorrhagic potential of this tumor, 
some authors have already reported high incidences of pre-
senting with bleeding, 87% of duodenal GISTs and 64% of 
other small bowel GISTs. Other locations like gastric, rectal 
or colonic are associated with less than 45% incidence of 
bleeding [12].
In conclusion, GI bleeding in patients can be caused by 
GISTs tumors. Even if rare, they must be included in the dif-
ferential diagnosis. Treatment is still complete surgical re-
section.
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